Integrated Biotherapeutics

Founded in 2005. Integrated BioTherapeutics (IBT) is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging diseases.

[Integrated Biotherapeutics @IBT_inc]

M. Javad Aman, Ph.D., President, and CEO of Integrated BioTherapeutics, discusses his Montgomery County-based company's R&D mission to develop vaccines and therapies to combat emerging infectious diseases.

For full video visit: https://t.co/1daZPto8Dq

[Integrated Biotherapeutics @IBT_inc]

"Here we report the development of pan-ebolavirus and pan-filovirus antibodies generated by repeated immunization of mice with filovirus glycoproteins engineered to drive the B cell responses toward conserved epitopes."

https://t.co/gwOBUSUPG7

[Integrated Biotherapeutics @IBT_inc]

"The severe death toll caused by the recent outbreak of Ebola virus disease reinforces the importance of developing ebolavirus prevention and treatment strategies."

#researchanddevelopment #vaccinedevelopment #biotechnology #vaccine #ebola #prevention

https://t.co/9nuoGfGB7r

[Integrated Biotherapeutics @IBT_inc]

To the backbone of our future, Happy Parents Day from IBT

[Integrated Biotherapeutics @IBT_inc]

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

#researchanddevelopment #research #vaccinedevelopment #biotechnology #VaccineRollOutSA

https://t.co/vp8luw54rq

[Integrated Biotherapeutics @IBT_inc]

Check this out!

IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus

#researchanddevelopment #research #vaccinedevelopment #biotechnology #vaccine

https://t.co/8bmHqaS2Ae

[Integrated Biotherapeutics @IBT_inc]

Check out our publication: Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody

https://t.co/2RTpZPdGz3

[Integrated Biotherapeutics @IBT_inc]

IBT works diligently to help control infectious diseases through our antiviral and antibacterial research programs.

#antiviral #antibacterial #pipeline #infectiousdiseases

Take a look at our technology platforms and pipelines: https://t.co/9w3NlOmcJz

[Integrated Biotherapeutics @IBT_inc]

What can the history of antimicrobial resistance tell us about future pandemics?
#publicheath #antimicrobials #antimicrobialresistance #researchanddevelopment
https://t.co/iKN3aWYZh6

[Integrated Biotherapeutics @IBT_inc]

Our team has extensive experience in molecular and enzymatic assays, and immunoassays as single- and multiplexed platforms. Visit the IBT Bioservices website to learn more.
#flowcytometry #assaydevelopment #proteinpurification
https://t.co/7iHMP0zLPq

[Integrated Biotherapeutics @IBT_inc]

Happy Juneteenth from Integrated BioTherapeutics

[Integrated Biotherapeutics @IBT_inc]

IBT Receives Phase I SBIR grant from NIAID for development of Novel ISTAb therapeutics for Staph aureus #NIH #grant #development #therapeutics

Full view here: https://t.co/bMflZw3Gmi

[Minority Health @MinorityHealth]

Let’s come together this June to celebrate the progress that has been made to promote health equity for the LGBTQ+ community and reflect on the work ahead. https://t.co/4ublePajje #Pride #PrideMonth

[Integrated Biotherapeutics @IBT_inc]

IBT Receives Phase I/II Fast Track SBIR grant from NIAID for development of broadly protective monoclonal antibodies against Influenza Virus (INFV) #NIAID #development #influenza #virus

Read the full story:
https://t.co/8QImvWxh5w

[Integrated Biotherapeutics @IBT_inc]

IBT Receives Phase I SBIR grant from NIAID for development of neutralizing monoclonal antibodies against Marburg Virus #development #marburg #grant #NIAID

Full read here: https://t.co/F0IF3bKq2Z

[Integrated Biotherapeutics @IBT_inc]

IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
Read more here: https://t.co/BrQexYKuMA

[Integrated Biotherapeutics @IBT_inc]

Happy Monday everyone, it's a great day to save lives!
#biotherapeutics #research #RandD

[Integrated Biotherapeutics @IBT_inc]

CARB-X funds Integrated BioTherapeutics to expand the development of its staphylococcus aureus vaccine to facilitate use in the developing world #vaccine #research #development #innovative

Read more here: https://t.co/8ngqI4iLSr

[Integrated Biotherapeutics @IBT_inc]

Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides a strategic update!

View the full article here: https://t.co/yWs0p319EL

[Integrated Biotherapeutics @IBT_inc]

Recent clinical successes of monoclonal antibodies (mAbs) in therapy for viral infections demonstrate that mAbs offer a solution for these emerging biothreats.
#immunotherapy #antibodies #researchanddevelopment

https://t.co/2RTpZPvhXD